1	Britain	NNP	6	poss
2	's	POS	1	possessive
3	Monopolies	NNP	6	nn
4	and	CC	3	cc
5	Mergers	NNP	3	conj
6	Commission	NNP	8	nsubj
7	Wednesday	NNP	8	tmod
8	cleared	VBD	0	root
9	Rhone-Poulenc	NNP	10	nn
10	S.A.	NNP	12	poss
11	's	POS	10	possessive
12	purchase	NN	8	dobj
13	of	IN	12	prep
14	a	DT	17	det
15	specialty	NN	17	nn
16	bulk-chemical	NN	17	nn
17	unit	NN	13	pobj
18	from	IN	12	prep
19	Monsanto	NNP	20	nn
20	Co.	NNP	18	pobj
21	,	,	8	punct
22	saying	VBG	8	partmod
23	the	DT	24	det
24	purchase	NN	26	nsubj
25	was	VBD	26	cop
26	unlikely	JJ	22	ccomp
27	to	TO	28	aux
28	have	VB	26	xcomp
29	any	DT	31	det
30	lasting	JJ	31	amod
31	impact	NN	28	dobj
32	on	IN	31	prep
33	U.K.	NNP	35	nn
34	industrial	JJ	35	amod
35	consumers	NNS	32	pobj
36	.	.	8	punct

1	The	DT	2	det
2	commission	NN	24	nsubj
3	,	,	2	punct
4	which	WDT	6	nsubjpass
5	was	VBD	6	auxpass
6	asked	VBN	2	rcmod
7	to	TO	8	aux
8	study	VB	6	xcomp
9	the	DT	10	det
10	deal	NN	8	dobj
11	by	IN	6	prep
12	the	DT	13	det
13	Department	NNP	11	pobj
14	of	IN	13	prep
15	Trade	NNP	14	pobj
16	and	CC	15	cc
17	Industry	NNP	15	conj
18	after	IN	6	prep
19	its	PRP$	20	poss
20	announcement	NN	18	pobj
21	in	IN	20	prep
22	February	NNP	21	pobj
23	,	,	2	punct
24	said	VBD	0	root
25	the	DT	26	det
26	diversity	NN	38	nsubj
27	of	IN	26	prep
28	global	JJ	29	amod
29	supply	NN	27	pobj
30	of	IN	29	prep
31	chemicals	NNS	30	pobj
32	used	VBN	31	partmod
33	in	IN	32	prep
34	making	VBG	33	pcomp
35	analgesic	JJ	36	amod
36	drugs	NNS	34	dobj
37	was	VBD	38	cop
38	great	JJ	24	ccomp
39	enough	RB	38	advmod
40	to	TO	41	aux
41	offset	VB	38	xcomp
42	the	DT	46	det
43	dominant	JJ	46	amod
44	U.K.	NNP	46	nn
45	market	NN	46	nn
46	share	NN	41	dobj
47	Rhone-Poulenc	NNP	49	nsubj
48	would	MD	49	aux
49	gain	VB	46	rcmod
50	through	IN	49	prep
51	the	DT	52	det
52	acquisition	NN	50	pobj
53	.	.	24	punct

1	The	DT	4	det
2	French	NNP	4	nn
3	chemical	NN	4	nn
4	giant	NN	6	nsubj
5	would	MD	6	aux
6	hold	VB	0	root
7	an	DT	10	det
8	80	CD	9	number
9	%	NN	10	amod
10	share	NN	6	dobj
11	of	IN	10	prep
12	the	DT	14	det
13	U.K.	NNP	14	nn
14	market	NN	11	pobj
15	for	IN	14	prep
16	salicylic	JJ	17	amod
17	acid	NN	15	pobj
18	,	,	17	punct
19	methyl	NN	20	nn
20	salicylate	NN	17	conj
21	and	CC	17	cc
22	bulk	JJ	23	amod
23	aspirin	NN	17	conj
24	.	.	6	punct

1	The	DT	2	det
2	commission	NN	3	nsubj
3	found	VBD	0	root
4	that	IN	18	complm
5	if	IN	9	mark
6	the	DT	8	det
7	British	JJ	8	amod
8	government	NN	9	nsubj
9	attempted	VBD	18	advcl
10	to	TO	11	aux
11	block	VB	9	xcomp
12	the	DT	13	det
13	merger	NN	11	dobj
14	,	,	18	punct
15	Rhone-Poulenc	NNP	18	nsubj
16	would	MD	18	aux
17	likely	RB	18	advmod
18	respond	VB	3	ccomp
19	by	IN	18	prep
20	closing	VBG	19	pcomp
21	the	DT	23	det
22	salicylates	NNS	23	nn
23	plant	NN	20	dobj
24	Monsanto	NNP	25	nsubj
25	operates	VBZ	23	rcmod
26	in	IN	23	prep
27	Wales	NNP	26	pobj
28	,	,	18	punct
29	removing	VBG	18	xcomp
30	the	DT	31	det
31	matter	NN	29	dobj
32	from	IN	29	prep
33	U.K.	NNP	34	nn
34	jurisdiction	NN	32	pobj
35	.	.	3	punct


